My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

6.710 +0.360 (+5.67%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Myriad Genetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

1 High-Flying Stock with Solid Fundamentals and 2 We Question

November 13, 2025

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

Topics Artificial Intelligence Economy

Merck, Elanco, Myriad Genetics, Neogen, and Cigna Shares Are Soaring, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

The Top 5 Analyst Questions From Myriad Genetics’s Q3 Earnings Call

November 10, 2025

Myriad Genetics’ third quarter saw revenue and adjusted profit in line with Wall Street expectations, but the market reacted negatively due to ongoing challenges in average revenue per test and...

Via StockStory

Topics Earnings

Earnings Scheduled For November 3, 2025 ↗

November 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 04, 2025

Via Benzinga

Why Myriad Genetics (MYGN) Stock Is Down Today

November 04, 2025

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) fell 19.3% in the morning session after it reported mixed third-quarter results that were overshadowed by a weak earnings outlook.

Via StockStory

Topics Economy Government World Trade

MYGN Q3 Deep Dive: Oncology Growth and Product Launches Offset Market Headwinds

November 04, 2025

Genetic testing company Myriad Genetics (NASDAQ:MYGN) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 3.6% year on year to $205.7 million. The company’s outlook for the full year...

Via StockStory

Myriad Genetics’s (NASDAQ:MYGN) Q3 Earnings Results: Revenue In Line With Expectations But Stock Drops

November 03, 2025

Via StockStory

What To Expect From Myriad Genetics’s (MYGN) Q3 Earnings

November 01, 2025

Genetic testing company Myriad Genetics (NASDAQ:MYGN) will be reporting results this Monday after the bell. Here’s what to expect.

Via StockStory

Exploring Myriad Genetics's Earnings Expectations ↗

October 31, 2025

Via Benzinga

1 Stock Under $10 Worth Your Attention and 2 Facing Challenges

October 30, 2025

Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be...

Via StockStory

October 17, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

3 Cash-Burning Stocks with Open Questions

October 14, 2025

While some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth. A high cash burn rate without a strong balance sheet can leave investors exposed to...

Via StockStory

Myriad Genetics, Omnicell, Globus Medical, Repligen, and Teleflex Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Topics Economy Government World Trade

A Look Back at Therapeutics Stocks’ Q2 Earnings: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Pack

October 01, 2025

Looking back on therapeutics stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Myriad Genetics (NASDAQ:MYGN) and its peers.

Via StockStory

Topics Artificial Intelligence

3 Unprofitable Stocks That Fall Short

September 30, 2025

Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth.

Via StockStory

3 Small-Cap Stocks That Concern Us

September 17, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Firing on All Cylinders: Biogen (NASDAQ:BIIB) Q2 Earnings Lead the Way

September 16, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q2, starting with Biogen...

Via StockStory

Topics Artificial Intelligence

1 Momentum Stock for Long-Term Investors and 2 Facing Challenges

September 15, 2025

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro...

Via StockStory

3 Russell 2000 Stocks with Open Questions

September 05, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Topics Regulatory Compliance

3 Stocks Under $10 We Approach with Caution

August 22, 2025

Via StockStory

Opendoor, SmartRent, Myriad Genetics, Reddit, and Unity Stocks Trade Down, What You Need To Know

August 20, 2025

A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this...

Via StockStory

Topics Artificial Intelligence Economy World Trade

3 Healthcare Stocks We’re Skeptical Of

August 18, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six...

Via StockStory

Topics Stocks

MYGN Q2 Deep Dive: Oncology Strategy Shift and Product Execution Shape Guidance

August 13, 2025

Genetic testing company Myriad Genetics (NASDAQ:MYGN) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $213.1 million. The company’s full-year...

Via StockStory

Topics Artificial Intelligence

What's going on in today's session ↗

August 06, 2025

Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Why Is Myriad Genetics (MYGN) Stock Soaring Today

August 06, 2025

Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 36.4% in the afternoon session after the company reported strong second-quarter earnings that surpassed analyst expectations and...

Via StockStory

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 06, 2025

Via Benzinga

Here are the top movers in Wednesday's session. ↗

August 06, 2025

Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Shopify, Astera Labs, Myriad Genetics, Grocery Outlet And Other Big Stocks Moving Higher On Wednesday ↗

August 06, 2025

Via Benzinga

The market is filled with gapping stocks in Wednesday's session. ↗

August 06, 2025

Traders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.